Sorafenib Completed Phase 1 Trials for Non Small Cell Lung Carcinoma (NSCLC) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00954278Intra-patient Dose Escalation Study of Sorafenib in Advanced Non-small Cell Lung Cancer